> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Boehringer Ingelheim
- URL: https://www.whiteroseintelligence.com/boehringer-ingelheim/
- Published: 1999-01-02T12:06:00.000Z
- Updated: 2026-01-08T19:39:04.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Boehringer Ingelheim** is a German pharmaceutical company based in Ingelheim, Germany.

## COVID-19

In March 2020, Boehringer Ingelheim joined the [COVID-19 Therapeutics Accelerator](https://www.whiteroseintelligence.com/COVID-19-Therapeutics-Accelerator) as a financial supporter.[\[1\]](#fn1)

Boehringer Ingelheim is a member of the Corona Accelerated R&D in Europe (CARE) consortium, developing therapeutics for COVID-19.[\[2\]](#fn2)

Boehringer Ingelheim ran clinical trials for their neutralizing antibody product BI 764198 in COVID-19 patients. The trials were suspended due to lack of efficacy.[\[3\]](#fn3) Meanwhile, the company also manufactures veterinary ivermectin products and advises against human consumption, instead advocating for [COVID-19 vaccination](https://www.whiteroseintelligence.com/COVID-19-vaccine).[\[4\]](#fn4)

## Organization

Boehringer Ingelheim has been a member or partner of:

- [AcademyHealth](https://www.whiteroseintelligence.com/AcademyHealth)[\[5\]](#fn5)
- [Ad Standards](https://www.whiteroseintelligence.com/Ad-Standards)[\[6\]](#fn6)
- [American Psychiatric Association Foundation](https://www.whiteroseintelligence.com/American-Psychiatric-Association-Foundation) Corporate Circle[\[7\]](#fn7)
- AMR Industry Alliance[\[8\]](#fn8)
- Arthritis Society[\[9\]](#fn9)
- [Biotechnology Innovation Organization](https://www.whiteroseintelligence.com/Biotechnology-Innovation-Organization) (BIO)[\[10\]](#fn10)
- Cardiac Arrhythmia Network of Canada[\[11\]](#fn11)
- Canadian Biosimilars Forum[\[12\]](#fn12)
- Canadian Stroke Prevention Intervention Network (C-SPIN)[\[13\]](#fn13)
- [C.D. Howe Institute](https://www.whiteroseintelligence.com/C-D-Howe-Institute)[\[14\]](#fn14)
- Decentralized Trials & Research Alliance (DTRA)[\[15\]](#fn15)
- Drugs for Neglected Diseases Initiative (DNDi)[\[16\]](#fn16)
- Endocrine Society Corporate Liaison Board[\[17\]](#fn17)
- European Federation of Pharmaceutical Industries and Associations (EFPIA)[\[18\]](#fn18)
- GBCHealth[\[19\]](#fn19)
- Global Health Progress[\[20\]](#fn20)
- Health Products Stewardship Association (HPSA)[\[21\]](#fn21)
- [Innovative Medicines Canada](https://www.whiteroseintelligence.com/Innovative-Medicines-Canada)[\[22\]](#fn22)
- International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)[\[23\]](#fn23)
- [National Health Council](https://www.whiteroseintelligence.com/National-Health-Council)[\[24\]](#fn24)
- National Organization for Rare Disorders (NORD) Corporate Council[\[25\]](#fn25)
- National Pharmaceutical Council (NPC)[\[26\]](#fn26)
- Northeast Business Group on Health[\[27\]](#fn27)
- Pallium Canada[\[28\]](#fn28)
- [Pharmaceutical Research and Manufacturers of America](https://www.whiteroseintelligence.com/Pharmaceutical-Research-and-Manufacturers-of-America) (PhRMA)[\[29\]](#fn29)
- Plug and Play[\[30\]](#fn30)
- Radcliffe Cardiology[\[31\]](#fn31)
- Structural Genomics Consortium (SGC)[\[32\]](#fn32)
- [Vector Institute for Artificial Intelligence](https://www.whiteroseintelligence.com/Vector-Institute-for-Artificial-Intelligence)[\[33\]](#fn33)

Boehringer Ingelheim has been a client of Biotext Solutions,[\[34\]](#fn34) [Glover Park Group](https://www.whiteroseintelligence.com/Glover-Park-Group),[\[35\]](#fn35) Knight Labs,[\[36\]](#fn36) Lyceum Health,[\[37\]](#fn37) Media Platforms,[\[38\]](#fn38) the Pharmaceutical Advertising Advisory Board (PAAB),[\[39\]](#fn39) RedNovius,[\[40\]](#fn40) Snell Medical Communication,[\[41\]](#fn41) STI Technologies,[\[42\]](#fn42) Trois Prime,[\[43\]](#fn43) and Vanguard Pharma.[\[44\]](#fn44)

### Personnel

| Name                  | Position                                                                                 | Notes                                                                                                                                                 |
| --------------------- | ---------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------- |
| Mehmood Alibhai       | Director of Patient Access and Healthcare Policy (Canada)[\[14:1\]](#fn14)               | [C.D. Howe Institute](https://www.whiteroseintelligence.com/C-D-Howe-Institute)                                                                       |
| Maria Anillo          | Senior Associate, Established Products and Regulatory Operations (Canada)[\[45\]](#fn45) | [Janssen](https://www.whiteroseintelligence.com/Janssen)                                                                                              |
| Takeshi Kei Kishimoto | Associate Director of Research (former)[\[46\]](#fn46)                                   | [Selecta Biosciences](https://www.whiteroseintelligence.com/Selecta-Biosciences)                                                                      |
| Youla Tsantrizos      | Group Leader and Distinguished Scientist (former)[\[47\]](#fn47)                         | [COVID-19 Therapeutics Task Force](https://www.whiteroseintelligence.com/COVID-19-Therapeutics-Task-Force), McGill University Department of Chemistry |

## Activities

Boehringer Ingelheim has provided notable funding to:

- [Alliance for Patient Access](https://www.whiteroseintelligence.com/Alliance-for-Patient-Access)[\[48\]](#fn48)
- [American Association for Cancer Research](https://www.whiteroseintelligence.com/American-Association-for-Cancer-Research) (AACR)[\[49\]](#fn49)
- [American Diabetes Association](https://www.whiteroseintelligence.com/American-Diabetes-Association) (ADA)[\[50\]](#fn50)
- [AMERIPAC](https://www.whiteroseintelligence.com/AMERIPAC)[\[51\]](#fn51)
- Arthritis Foundation[\[52\]](#fn52)
- BioFIT 2020[\[53\]](#fn53)
- Bipartisan Commission on Biodefense[\[54\]](#fn54)
- British Columbia Pharmacy Association (BCPhA)[\[55\]](#fn55)
- Canadian Association of Radiologists[\[56\]](#fn56)
- Canadian Cohort Obstructive Lung Disease[\[57\]](#fn57)
- Canadian HIV and Viral Hepatitis Pharmacists Network[\[58\]](#fn58)
- Canadian Lung Association (CLA)[\[59\]](#fn59)
- Canadian Rheumatology Association (CRA)[\[60\]](#fn60)
- Canadian Society of Nephrology[\[61\]](#fn61)
- Cardiac Arrhythmia Network of Canada (CANet)[\[62\]](#fn62)
- [CDC Foundation](https://www.whiteroseintelligence.com/CDC-Foundation)[\[63\]](#fn63)
- Colorectal Cancer Canada[\[64\]](#fn64)
- Consortium de recherche biopharmaceutique (CQDM)[\[65\]](#fn65)
- [COVID-19 Therapeutics Accelerator](https://www.whiteroseintelligence.com/COVID-19-Therapeutics-Accelerator)[\[1:1\]](#fn1)
- Crohn's & Colitis Foundation[\[66\]](#fn66)
- Diabetes Canada[\[67\]](#fn67)
- Equine Guelph[\[68\]](#fn68)
- European Society of Cardiology (ESC)[\[69\]](#fn69)
- Falling Walls Foundation[\[70\]](#fn70)
- Federation of Medical Women in Canada[\[71\]](#fn71)
- [Global Liver Institute](https://www.whiteroseintelligence.com/Global-Liver-Institute)[\[72\]](#fn72)
- Joseph Brant Hospital Foundation[\[73\]](#fn73)
- Kyla Hildebrand[\[74\]](#fn74)
- Lakeridge Health Foundation[\[75\]](#fn75)
- Lung Health Foundation[\[76\]](#fn76)
- Michael Garron Hospital Foundation[\[77\]](#fn77)
- Montreal Clinical Research Institute[\[78\]](#fn78)
- National Alliance on Mental Illness (NAMI)[\[79\]](#fn79)
- New Brunswick Health Research Foundation (NBHRF)[\[80\]](#fn80)
- Peter McCullough[\[81\]](#fn81)
- [PhRMA Foundation](https://www.whiteroseintelligence.com/PhRMA-Foundation)[\[82\]](#fn82)
- Princess Margaret Cancer Foundation[\[83\]](#fn83)
- Richard Choi[\[84\]](#fn84)
- Sinai Health Foundation[\[85\]](#fn85)
- St. Paul's Foundation[\[86\]](#fn86)
- University Health Network Foundation[\[87\]](#fn87)
- University Hospital Foundation[\[88\]](#fn88)
- University Hospitals Kingston Foundation[\[89\]](#fn89)
- University of Toronto[\[90\]](#fn90)
- University of Washington[\[91\]](#fn91)
- VGH & UBC Hospital Foundation[\[92\]](#fn92)
- Westminster Health Forum[\[93\]](#fn93)
- Women in Medicine Summit[\[94\]](#fn94)

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:boehringer%5Fingelheim)
- [Wikipedia](https://en.wikipedia.org/wiki/Boehringer%5FIngelheim)

---

1. Staines, R. (2020, March 26). *Pharma giants including Novartis collaborate on COVID-19 therapies.* Pharmaphorum. <http://archive.today/2022.01.18-165943/https://pharmaphorum.com/news/collaborate-covid19-therapies/> [↩︎](#fnref1) [↩︎](#fnref1:1)
2. *COVID-19: CARE Consortium.* Boehringer Ingelheim. Retrieved January 12, 2022, from <http://archive.vn/2022.01.12-220304/https://www.boehringer-ingelheim.com/covid-19/fighting-covid-19/imi2-call-21> [↩︎](#fnref2)
3. *Study in COVID-19 Patients with Severe Respiratory Illness Discontinued.* Boehringer Ingelheim. Retrieved July 30, 2021, from <https://web.archive.org/web/20210730233935/https://www.boehringer-ingelheim.com/covid-19/fighting-covid-19/research-update> [↩︎](#fnref3)
4. *Ivermectin in Animal Health products and COVID-19.* Boehringer Ingelheim. Retrieved January 12, 2022, from <http://archive.vn/2022.01.12-220435/https://www.boehringer-ingelheim.com/covid-19/protecting-humans-and-animals/ivermectin-animal-health-not-for-human-use> [↩︎](#fnref4)
5. *Current Organizational Members.* AcademyHealth. Retrieved May 8, 2022, from <http://archive.vn/2022.05.08-091859/https://academyhealth.org/membership/organizational-members/current-organizational-members/page/current-organizational-members> [↩︎](#fnref5)
6. *Member Logos.* Ad Standards. Retrieved September 17, 2021, from <https://web.archive.org/web/20210917052119/https://adstandards.ca/about/membership/member-logos/> [↩︎](#fnref6)
7. *Corporate Alliance.* American Psychiatric Association Foundation. Retrieved October 16, 2022, from <http://archive.vn/2022.10.16-182356/https://apafdn.org/about/corporate-alliance> [↩︎](#fnref7)
8. *Our Members.* (2017). AMR Industry Alliance. <https://web.archive.org/web/20220331155516/https://www.amrindustryalliance.org/our-members/> [↩︎](#fnref8)
9. *Partners.* The Arthritis Society. Retrieved May 14, 2022, from <http://archive.vn/2022.05.14-211808/https://arthritis.ca/about-us/partners> [↩︎](#fnref9)
10. *BIO Member Directory.* Biotechnology Innovation Organization. Retrieved September 30, 2022, from <https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory> [↩︎](#fnref10)
11. *About Us.* Cardiac Arrhythmia Network of Canada (CANet). Retrieved July 1, 2023 fom <https://web.archive.org/web/20230701175514/https://canet-nce.ca/about/> [↩︎](#fnref11)
12. *Registration - Canadian Biosimilars Forum / Forum canadien des biosimilaires / Ross Wallace, Consultant.* (2022, October 4). Office of the Commissioner of Lobbying of Canada. <https://web.archive.org/web/20221008182918/https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/vwRg?cno=358995&regId=865127#regStart> [↩︎](#fnref12)
13. *Partners.* Canadian Stroke Prevention Intervention Network. Retrieved June 14, 2022, from <http://archive.vn/2022.06.14-175210/https://www.cspin.ca/about-us/partners/index.html> [↩︎](#fnref13)
14. *Annual Report 2021.* C.D. Howe Institute. Retrieved November 9, 2022, from <https://web.archive.org/web/20221109082150/https://www.cdhowe.org/sites/default/files/2022-09/2021%5FAR%5FEnglish%5F0525%5F0.pdf> [↩︎](#fnref14) [↩︎](#fnref14:1)
15. *DTRA Founding Member Organizations.* Decentralized Trials & Research Alliance. Retrieved January 18, 2023, from <https://web.archive.org/web/20230118082926/https://www.dtra.org/founding-members> [↩︎](#fnref15)
16. *Industry partners and service providers.* DNDi. Retrieved June 3, 2022, from <http://archive.vn/2022.06.03-181048/https://dndi.org/partnerships/industry-partners/> [↩︎](#fnref16)
17. *Corporate Liaison Board.* Endocrine Society. Retrieved June 10, 2022, from <http://archive.vn/2022.06.10-234024/https://www.endocrine.org/membership/corporate-liaison-board> [↩︎](#fnref17)
18. *Membership*. (2022). European Federation of Pharmaceutical Industries and Association. <https://web.archive.org/web/20220701031757/https://www.efpia.eu/about-us/membership/> [↩︎](#fnref18)
19. *GBCHealth Member Directory* (archived). GBCHealth. Retrieved January 11, 2023, from <http://archive.today/2023.01.11-041556/https://archive.gbchealth.org/our-coalition/member-directory/> [↩︎](#fnref19)
20. *Explore Our Collaborations.* (2022). Global Health Progress. <https://web.archive.org/web/20220403013206/https://globalhealthprogress.org/explore-our-collaborations/> [↩︎](#fnref20)
21. *Members.* Health Products Stewardship Association. Retrieved April 27, 2022, from <http://archive.vn/2022.04.27-100339/https://healthsteward.ca/members/hpsa-members/> [↩︎](#fnref21)
22. *Member Companies.* Innovative Medicines Canada. Retrieved April 14, 2021, from <https://web.archive.org/web/20210414150341/http://innovativemedicines.ca/about/member-companies/> [↩︎](#fnref22)
23. *Companies*. IFPMA. Retrieved July 1, 2022, from <https://web.archive.org/web/20220701150736/https://www.ifpma.org/who-we-are/our-membership/full-members/companies/> [↩︎](#fnref23)
24. *Our Members.* National Health Council. Retrieved April 6, 2022, from <https://web.archive.org/web/20220406081753/https://nationalhealthcouncil.org/members/?m%5Fcat=74&m%5Fkey=> [↩︎](#fnref24)
25. *Current NORD Corporate Council Members.* NORD (National Organization for Rare Disorders). Retrieved October 12, 2022, from <https://web.archive.org/web/20221012043656/https://rarediseases.org/get-involved/corporate-council/current-members/> [↩︎](#fnref25)
26. *Members.* National Pharmaceutical Council. Retrieved April 6, 2022, from <https://web.archive.org/web/20211102074208/https://www.npcnow.org/about/members> [↩︎](#fnref26)
27. *Members*. (2022). Northeast Business Group on Health. <https://nebgh.org/wp-content/uploads/2022/05/NEBGH-MemberList-051622b.pdf> [↩︎](#fnref27)
28. *Our Partners.* Pallium Canada. Retrieved November 29, 2022, from <https://web.archive.org/web/20221129014941/https://www.pallium.ca/our-partners/> [↩︎](#fnref28)
29. *About.* PhRMA. Retrieved September 14, 2023, from <https://web.archive.org/web/20230914221250/https://phrma.org/About> [↩︎](#fnref29)
30. *Our Corporate Innovation Partners.* Plug and Play Tech Center. Retrieved June 6, 2023, from <https://web.archive.org/web/20230606002503/https://www.plugandplaytechcenter.com/corporations/partners/> [↩︎](#fnref30)
31. *A-Z.* (2022). Radcliffe Cardiology. <https://web.archive.org/web/20220612062914/https://www.radcliffecardiology.com/products-services/a-z> [↩︎](#fnref31)
32. *SGC Collaborators and Partners.* Structural Genomics Consortium. Retrieved April 9, 2023, from <https://web.archive.org/web/20230409220032/https://www.thesgc.org/collaborators> [↩︎](#fnref32)
33. *Current Partners.* Vector Institute for Artificial Intelligence. Retrieved July 5, 2023, from <https://web.archive.org/web/20230705190023/https://vectorinstitute.ai/partnerships/current-partners/> [↩︎](#fnref33)
34. *Home.* Biotext Solutions. Retrieved August 30, 2022, from <http://archive.vn/2022.08.30-055440/http://www.biotext.ca/%23testimonials> [↩︎](#fnref34)
35. *Lobbying Firm Profile: Glover Park Group - 2020.* OpenSecrets. Retrieved February 15, 2024, from <http://archive.vn/2024.02.15-232559/https://www.opensecrets.org/federal-lobbying/firms/summary?cycle=2020&id=D000034089> [↩︎](#fnref35)
36. *Clients*. KNIGHTLABS | Read between the Data. Retrieved August 31, 2022, from <https://web.archive.org/web/20220901041841/https://klabs.com/#clients> [↩︎](#fnref36)
37. *Home*. Lyceum Health. Retrieved September 1, 2022, from <https://web.archive.org/web/20220901064045/https://www.lyceumhealth.com/> [↩︎](#fnref37)
38. *Clients*. Media Platforms. Retrieved September 1, 2022, from <http://archive.vn/2022.09.01-065723/https://www.mediaplatforms.ca/clients/index.html> [↩︎](#fnref38)
39. *About*. Pharmaceutical Advertising Advisory Board. Retrieved January 8, 2018, from <http://archive.vn/2022.08.29-054034/https://web.archive.org/web/20180108160414/http://www.paab.ca/about.htm> [↩︎](#fnref39)
40. *Home*. RedNovius | Digital Pharma Marketing Company. Retrieved September 2, 2022, from <https://web.archive.org/web/20220524110620/https://www.rednovius.com/> [↩︎](#fnref40)
41. *Clients*. Snell Medical Communication. Retrieved September 5, 2022, from <http://archive.vn/2022.09.04-161503/https://www.snellmedical.com/clients> [↩︎](#fnref41)
42. *Home*. STI Technologies Limited. Retrieved September 2, 2022, from <https://web.archive.org/web/20220626020749/https://smartsti.com/> [↩︎](#fnref42)
43. *Clients*. Trois Prime. Retrieved September 3, 2022, from <http://archive.vn/2022.09.03-010026/https://www.troisprime.com/clients> [↩︎](#fnref43)
44. *Clients - About Us.* Vanguard Pharma. Retrieved October 16, 2021, from <https://web.archive.org/web/20211016085207/https://www.vanguardpharma.com/about-us/clients/> [↩︎](#fnref44)
45. *Speakers*. DIA Global. Retrieved May 28, 2023, from <https://web.archive.org/web/20230528061502/https://www.diaglobal.org/en/conference-listing/meetings/2022/10/canada-annual-meeting/speakers> [↩︎](#fnref45)
46. *Takashi Kei Kishimoto, Ph.D. | Management.* Cartesian Therapeutics. Retrieved January 6, 2025, from <https://ir.cartesiantherapeutics.com/management/takashi-kei-kishimoto-phd> [↩︎](#fnref46)
47. *Youla Tsantrizos.* McGill University Department of Chemistry. Retrieved January 6, 2025, from <https://web.archive.org/web/20241206213902/https://www.mcgill.ca/chemistry/faculty/youla-tsantrizos> [↩︎](#fnref47)
48. *Associate Members and Financial Supporters.* (2022, January). Alliance for Patient Access. <https://web.archive.org/web/20220128105843/https://admin.allianceforpatientaccess.org/wp-content/uploads/2022/01/AfPADonorsJanuary2022.pdf> [↩︎](#fnref48)
49. *Supporters.* American Association for Cancer Research (AACR). Retrieved January 29, 2023, from <http://archive.today/2023.05.11-051652/https://www.aacr.org/meeting/aacr-annual-meeting-2021/supporters/> [↩︎](#fnref49)
50. Henderson, C. (2022, September). *Annual Report 2021: The Big Step Up.* American Diabetes Association. <https://web.archive.org/web/20221019182708/https://diabetes.org/sites/default/files/2022-09/2021-ADAAnnualReport.pdf> [↩︎](#fnref50)
51. *Browse Receipts - AMERIPAC: The Fund For A Greater America - 2019-2020.* Federal Election Commission. Retrieved April 18, 2024, from <https://www.fec.gov/data/receipts/?data%5Ftype=processed&committee%5Fid=C00271338&two%5Fyear%5Ftransaction%5Fperiod=2020> [↩︎](#fnref51)
52. *Partnership Opportunities.* Arthritis Foundation. Retrieved October 16, 2022, from <https://web.archive.org/web/20221016171837/https://www.arthritis.org/partnership> [↩︎](#fnref52)
53. *2020 Participants.* BioFIT 2022\. Retrieved June 12, 2022, from <http://archive.vn/2022.06.12-194911/https://www.biofit-event.com/2020-participants/> [↩︎](#fnref53)
54. *Sponsors / Donors.* Bipartisan Commission on Biodefense. Retrieved May 28, 2022, from <http://archive.vn/2022.05.29-040043/https://biodefensecommission.org/sponsors-donors/> [↩︎](#fnref54)
55. *Our Sponsors and Prizes.* BC Pharmacy Association. Retrieved May 22, 2022, from <http://archive.vn/2022.05.23-043337/https://www.bcpharmacy.ca/conference/prizes/2022> [↩︎](#fnref55)
56. *Corporate Partners.* Canadian Association of Radiologists. Retrieved July 19, 2022, from <http://archive.today/2022.07.19-153232/https://car.ca/about/corporate-partners/> [↩︎](#fnref56)
57. *Home*. CanCOLD. Retrieved January 9, 2022, from <http://archive.vn/2022.01.09-211553/https://cancold.ca/> [↩︎](#fnref57)
58. *CHAP Annual Meetings.* Canadian HIV and Viral Hepatitis Pharmacists Network. Retrieved April 19, 2022, from <http://archive.vn/2022.04.19-182055/https://hivclinic.ca/chap/sponsors.php> [↩︎](#fnref58)
59. *About Us.* Canadian Lung Association. Retrieved January 10, 2022,  
from <http://archive.vn/2022.01.10-091150/https://www.lung.ca/about-us> [↩︎](#fnref59)
60. *2019-2020 Annual Report.* (2020). Canadian Rheumatology Association. <https://web.archive.org/web/20220301060726/https://rheum.ca/wp-content/uploads/2020/09/ARD20%5FCR02%5FP01%5Fcra%5Fscr%5Fannual%5Freport%5F2020%5Fv8b.pdf> [↩︎](#fnref60)
61. *Our Partners.* CSN/SCN. Retrieved January 8, 2022, from <http://archive.vn/2022.01.08-161403/https://www.csnscn.ca/our-partners/> [↩︎](#fnref61)
62. *About.* Cardiac Arrhythmia Network of Canada — CANet. Retrieved January 6, 2025, from <https://web.archive.org/web/20250106043804/https://canet-nce.ca/about/> [↩︎](#fnref62)
63. *Organizations - FY2014.* CDC Foundation. Retrieved August 9, 2022, from <https://web.archive.org/web/20220809071203/https://www.cdcfoundation.org/FY2014/organizations> [↩︎](#fnref63)
64. *Our Partnerships.* (2021). Colorectal Cancer Canada. <https://web.archive.org/web/20220516082302/https://www.colorectalcancercanada.com/what-we-do/our-partnerships/> [↩︎](#fnref64)
65. *Home*. CQDM - Consortium de Recherche Biopharmaceutique. Retrieved September 13, 2022, from <http://archive.today/2022.09.13-150313/https://cqdm.org/en/> [↩︎](#fnref65)
66. *Meet Our Partners.* Crohn’s & Colitis Foundation. Retrieved October 16, 2022, from <http://archive.today/2022.10.16-023856/https://www.crohnscolitisfoundation.org/about/meet-our-partners> [↩︎](#fnref66)
67. *2020 Impact Report.* (2020). Diabetes Canada. <https://web.archive.org/web/20220121173802/https://diabetes.ca/DiabetesCanadaWebsite/media/AboutDiabetesCanada/Finance/DC-2020-Impact-Report-DIGITAL.pdf> [↩︎](#fnref67)
68. *Sponsors*. Equine Guelph. Retrieved January 28, 2022, from <http://archive.vn/2022.01.28-181011/https://www.equineguelph.ca/about%5Fus/sponsors.php> [↩︎](#fnref68)
69. *Why sponsor the EURObservational Registry Programme.* European Society of Cardiology. Retrieved June 15, 2022, from <http://archive.vn/2022.06.15-200912/https://www.escardio.org/Research/Registries-&-surveys/Sponsorship> [↩︎](#fnref69)
70. *Our Partners.* Falling Walls. Retrieved November 3, 2022, from <https://web.archive.org/web/20221103045913/https://falling-walls.com/foundation/partners/> [↩︎](#fnref70)
71. Hellyer, D., Cannon, C., Canty, A., Schwartz, J., Gamache, N., Preuss, C., Ross, S., DeGirolamo, K., Verma, P., White, C., & Younger-Lewis, C. (2010). *AGM 2010: The Many Faces of Medical Women.* Federation of Medical Women of Canada Newsletter, 23(3), 1, 2, 16\. <https://web.archive.org/web/20220306100332/https://fmwc.ca/wp-content/uploads/2013/12/FMWC%5FFall%5FIssue%5F2010.pdf> [↩︎](#fnref71)
72. *Who We Are.* Global Liver Institute. Retrieved July 10, 2023, from <https://web.archive.org/web/20230710042334/https://globalliver.org/who-we-are/> [↩︎](#fnref72)
73. *Donor Recognition.* Joseph Brant Hospital Foundation. Retrieved December 15, 2024, from <https://jbhfoundation.ca/donor-recognition/> [↩︎](#fnref73)
74. Quirt, J., Hildebrand, K. J., Mazza, J., Noya, F., & Kim, H. (2018). Practical guide for allergy and immunology in Canada 2018\. *Allergy, Asthma & Clinical Immunology, 14*(S2). <https://doi.org/10.1186/s13223-018-0279-0> [↩︎](#fnref74)
75. *Donor Recognition.* Lakeridge Health Foundation. Retrieved August 14, 2024, from <https://web.archive.org/web/20240814201358/https://lhfoundation.ca/Your-Impact/Donor-Recognition> [↩︎](#fnref75)
76. *Our Partners.* Lung Health Foundation. Retrieved June 9, 2022, from <http://archive.vn/2022.06.09-004346/https://lunghealth.ca/our-partners/> [↩︎](#fnref76)
77. *2019/2020 Annual Report.* Michael Garron Hospital Foundation. <https://www.mghf.ca/sites/default/files/file-browser/mghf%5Far%5F2019%5F2020%5Ffinal%5Femail%5F081420.pdf> [↩︎](#fnref77)
78. Duplessis, P. (2022). *2021/2022 Annual Report.* Montreal Clinical Research Institute. [https://web.archive.org/web/20240208035912/https://cdn.ca.yapla.com/company/CPY7p4CO2sE1afW3ImwiLyBND/asset/files/\_Rapports-annuels/2022\_RA\_EN(1).pdf](https://web.archive.org/web/20240208035912/https://cdn.ca.yapla.com/company/CPY7p4CO2sE1afW3ImwiLyBND/asset/files/%5FRapports-annuels/2022%5FRA%5FEN%281%29.pdf) [↩︎](#fnref78)
79. Gillison Jr., D. H. *Annual Report 2021.* National Alliance on Mental Illness. Retrieved August 31, 2022, from <https://web.archive.org/web/20220831202624/https://www.nami.org/NAMI/media/NAMI-Media/PDFs/Financials/2021-NAMI-Annual-Report.pdf> [↩︎](#fnref79)
80. *Annual Report 2020–2021.* (2021). New Brunswick Health Research Foundation. <https://web.archive.org/web/20220328004553/https://nbhrf.com/wp-content/uploads/2021/11/2021-annual-report-final.pdf> [↩︎](#fnref80)
81. *Peter Andrew McCullough.* Open Payments Data - CMS. Retrieved February 2, 2024, from <https://openpaymentsdata.cms.gov/physician/335114> [↩︎](#fnref81)
82. Plump, A., & Miller, A. M. (2022, June). *2021 Annual Report.* PhRMA Foundation. <https://web.archive.org/web/20230219205032/https://www.phrmafoundation.org/wp-content/uploads/2022/06/PhRMAFoundation%5F2021AnnualReport.pdf> [↩︎](#fnref82)
83. *2021 Annual Report.* Princess Margaret Cancer Foundation. Retrieved April 19, 2022, from <https://web.archive.org/web/20211120191604/https://thepmcf.ca/getmedia/9b96649e-83ba-490a-bacc-f961904b94c8/Annual-Report-2021%5FDigital.pdf> [↩︎](#fnref83)
84. Verma, S., Bucci, C., Choi, R., & Gupta, A. (2020, June 12). *Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications.* CardioVascUpdate. [https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV Update Symposium-Presentation.pdf](https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf) [↩︎](#fnref84)
85. *Donor List - Cumulative.* Sinai Health Annual Report. Retrieved April 13, 2023, from <https://web.archive.org/web/20230413115409/https://www.sinaihealthannualreport.ca/donor-list-cumulative> [↩︎](#fnref85)
86. *Donor List.* Providence Healthcare Annual Report 2018/19\. Retrieved February 7, 2022, from <http://archive.vn/2022.02.08-021711/https://annualreport2019.providencehealthcare.org/donors/> [↩︎](#fnref86)
87. *2020/21 Report to Our Donors.* UHN Foundation. Retrieved May 6, 2022, from <https://web.archive.org/web/20220507012703/https://uhnfoundation.ca/who-we-are/publications/2020-21-report-to-our-donors/> [↩︎](#fnref87)
88. Abbott, J. (2021). *Thank you to our donors* (pp. 2–23). University Hospital Foundation. <https://web.archive.org/web/20220109041605/https://givetouhf.ca/app/uploads/2021/12/UHF-2021-HonouringDonors-WEB-v2.pdf> [↩︎](#fnref88)
89. *Recognizing Your Contribution.* Kingston University Hospital Foundation. Retrieved May 4, 2022, from <https://web.archive.org/web/20220504073124/https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution> [↩︎](#fnref89)
90. *Donor Listing.* University of Toronto Boundless Campaign. Retrieved May 16, 2022, from <http://archive.vn/2021.04.23-095356/https://boundless.utoronto.ca/our-supporters/donor-listing/> [↩︎](#fnref90)
91. *Honor Roll of Donors.* University of Washington. Retrieved May 26, 2022, from <https://web.archive.org/web/20220610164520/https://uw-s3-cdn.s3.us-west-2.amazonaws.com/wp-content/uploads/sites/83/2020/10/29094302/RTC%5FHonorRoll%5F2020.pdf> [↩︎](#fnref91)
92. *Annual Report 2018-2019.* (2019). VGH & UBC Hospital Foundation. <https://web.archive.org/web/20221005044903/https://vghfoundation.ca/app/uploads/2019/10/Annual-Report-2018-19-web.pdf> [↩︎](#fnref92)
93. *Sponsorship at Westminster Forum Projects.* Westminster Forum Projects. Retrieved August 15, 2022, from <https://web.archive.org/web/20220815225216/https://www.westminsterforumprojects.co.uk/sponsorship> [↩︎](#fnref93)
94. *Sponsors*. Women in Medicine. Retrieved May 7, 2022, from <https://www.womeninmedicinesummit.org/sponsors> [↩︎](#fnref94)